Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein

Abstract

Breast cancer is the most common cancer among American women, whereas Asian women, who consume a traditional diet high in soy products, have a relatively low incidence. Genistein is a prominent isoflavonoid in soy products and has been proposed as the agent responsible for lowering the rate of breast cancer in Asian women. We investigated the effects of genistein on cell growth and apoptosis-related gene expression in breast cancer cells MDA-MB-231. We found up-regulation of Bax and p21WAF1 expressions and down-regulation of Bcl-2 and p53 expression in genistein-treated cells. Furthermore, DNA ladder formation, CPP32 activation, and PARP cleavage were observed after treatment with genistein, indicating apoptotic cell deaths. Flow cytometry with 7-amino actinomycin D staining showed that the number of apoptotic cells increased with longer treatment of genistein. From these results, we conclude that genistein inhibits the growth of MDA-MB-231 breast cancer cells, regulates the expression of apoptosis-related genes, and induces apoptosis through a p53-independent pathway. The up-regulation of Bax and p21WAF1 may be the molecular mechanisms by which genistein induces apoptosis, however, further definitive studies are needed. These results suggest that genistein may be a potentially effective chemopreventive or therapeutic agent against breast cancer.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Adlercreutz H, Honjo H, Higashi A, Fotsis T, Hamalainen E, Hasegawa T and Okada H. . 1991 Am. J. Clin. Nutr. 54: 1093–1100.

  • Agarwal ML, Agarwal A, Taylor WR and Stark GR. . 1995 Proc. Natl. Acad. Sci. USA 92: 8493–8497.

  • Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M and Fukami Y. . 1987 J. Biol. Chem. 262: 5592–5595.

  • Barnes S. . 1995 J. Nutr. 125: 777S–783S.

  • Buckley AR, Buckley DJ, Gout PW, Liang HR and Blake M. . 1993 Mol. Cell. Endocrinol. 98: 17–25.

  • Chiarugi V, Magnelli L, Cinelli M and Basi G. . 1994 Cell. Mol. Biol. Res. 40: 603–612.

  • Constantinou A, Kiguchi K and Huberman E. . 1990 Cancer Res. 50: 2618–2624.

  • Darmon AJ, Nicholson DW and Bleackley RC. . 1995 Nature 377: 446–448.

  • Findley HW, Gu L, Yeager AM and Zhou M. . 1997 Blood 89: 2986–2993.

  • Fisher DE. . 1994 Cell 78: 539–542.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R and Trent JM. . 1993 Cell 75: 817–825.

  • Fotsis T, Pepper M, Adlercreutz H, Hase T, Montesano R and Schweigerer L. . 1995 J. Nutr. 125: 790S–797S.

  • Gescher A, Pastorino U, Plummer SM and Manson MM. . 1998 Br. J. Clin. Pharmacol. 45: 1–12.

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 241–251.

  • Huang P, Ballal K and Plunkett W. . 1997 Cancer Res. 57: 3407–3414.

  • Hunter T. . 1987 Cell 50: 823–829.

  • Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T and Bredesen DE. . 1994 Science 262: 1274–1277.

  • Kyle E, Neckers L, Takimoto C, Curt G and Bergan R. . 1997 Mol. Pharmacol. 51: 193–200.

  • Lamartiniere CA, Moore J, Holland M and Barnes S. . 1995 Proc. Soc. Exp. Biol. Med. 208: 120–123.

  • Lazebnik YA, Kaufmann SH, Desnoyers S, Poirer GG and Earnshaw WC. . 1994 Nature 371: 346–347.

  • Lee HP, Gourley L, Duffy SW, Esteve J, Lee J and Day NE. . 1991 Lancet 337: 1197–1200.

  • Lian F, Bhuiyan M, Li Y, Wall N, Kraut M and Sarkar FH. . 1998 Nutr. Cancer (in press).

  • Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishimo H and Aoike A. . 1993 Cancer Res. 53: 1328–1331.

  • Messina M and Barnes S. . 1991 J. Natl. Cancer Inst. 83: 541–546.

  • Messina MJ, Persky V, Setchell KD and Barnes S. . 1994 Nutr. Cancer 21: 113–131.

  • Morla AO, Draetta G, Beach D and Wang JY. . 1989 Cell 58: 193–203.

  • Parker SL, Tong T, Bolden S and Wingo P. . 1996 CA Cancer J. Clin. 65: 5–27.

  • Peterson G and Barnes S. . 1991 Biochem., Biophys. Res. Commun. 179: 661–667.

  • Peterson G and Barnes S. . 1993 Prostate 22: 335345.

  • Philpott NJ, Turner AJC, Scopes J, Mestby M, Marsh JCW, Gordon-Smith EC, Dalgleish AG and Gibson FM. . 1996 Blood 87: 2244–22551.

  • Salomons GS, Brady HJ, Verwijs-Janssen M, Van JD, Hart AA, Van H, Behren K and Smets LA. . 1997 Int. J. Cancer 71: 959–965.

  • Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M and Hla T. . 1995 Cancer Res. 55: 3785–3789.

  • Sedlak ML, Oltvai ZN, Yang E, Wang K, Boise LH and Thompson CB. . 1995 Proc. Natl. Acad. Sci. USA 92: 7934–7938.

  • Shao ZM, Alpaugh ML, Fontana JA and Barsky SH. . 1998 J. Cell. Biochem. 69: 44–54.

  • Spinozzi F, Pagliacci MC, Migliorati G, Moraca R, Grignani F, Riccardi C and Nicoletti I. . 1994 Leukemia Res. 18: 431–439.

  • Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirer GG, Salvesen GS and Dixit VM. . 1995 Cell 81: 801–809.

  • Uckun FM, Evans WE, Forsyth CJ, Waddick KG and Ahlgren LT. . 1995 Science 267: 886–891.

  • Ullrich A and Schlessinger J. . 1990 Cell 61: 203–212.

  • Vogelstein B and Kinzler KW. . 1992 Cell 70: 523–526.

  • Wang C and Furzer MS. . 1997 Nutr. Cancer 28: 236–247.

  • Wang TT, Sathyamoorthy N and Phang JM. . 1996 Carcinogen. 17: 272–275.

  • Williams GT and Smith CA. . 1993 Cell 74: 777–779.

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi and Beach D. (1993). . Nature 366: 701–704.

  • Yuan JM, Wang QS, Ross RK, Henderson BE and Yu MC. . 1995 Br. J. Cancer 71: 1353–1358.

  • Zhou Y and Lee AS. . 1998 J. Natl. Cancer Inst. 90: 381–388.

Download references

Acknowledgements

This project was substantially funded by a grant from the Department of Defense (USAMRMC/DOD, DMAD17-97-1-7328) awarded to Dr Fazlul H Sarkar and also funded by RGK foundation. We sincerely thank Patricia Arlauskas for editorial assistance.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Upadhyay, S., Bhuiyan, M. et al. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18, 3166–3172 (1999). https://doi.org/10.1038/sj.onc.1202650

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202650

Keywords

This article is cited by

Search

Quick links